Researcher Profile

Researcher Profile

Harold Harvey, MD

Harold Harvey, MD

Professor, Department of Medicine
Division of Hematology and Oncology
Disease Teams:
Breast Cancer
Sarcoma Cancer
hah1@psu.edu

Research Interests

  • Breast Neoplasms
  • Therapeutics
  • Neoplasms
  • Aminoglutethimide
  • Drug Therapy
  • Estrogens
  • Neoplasm Metastasis
  • Tamoxifen
  • Bone and Bones
  • Prostatic Neoplasms
  • Aromatase Inhibitors
  • Hydrocortisone

Clinical Trials

MATCH Treatment Subprotocol C2: Crizotinib in Patients with Tumors with MET Exon 14 Deletion
MATCH Treatment Subprotocol E: AZD9291 in Patients with Tumors Having EGFR T790M Mutations (Except Non-Small Cell Lung Cancer) or Rare Activating Mutations of EGFR
MATCH Treatment Subprotocol F: Crizotinib in Patients with Tumors (Other Than Adenocarcinoma of Lung or ALCL) with ALK Rearrangements
MATCH Treatment Subprotocol G: Phase II Study of Crizotinib in Patients with ROS1 Translocations (Other Than Patients with Non-Small Cell Lung Cancer)
MATCH Treatment Subprotocol T: GDC-0449 (vismodegib) in Patients with Tumors (except basal cell skin carcinoma) with Smoothened (SMO) or Patched 1 (PTCH1) Mutations
MATCH Treatment Subprotocol V: Phase II Study of Sunitinib in Patients with Tumors with c-Kit Mutations (Excluding GIST, Renal Cell Carcinoma or Pancreatic Neuroendocrine Tumor).
A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology

Recent Publications

2018

Cheng, Y, Ren, X, Yuan, Y, Shan, Y, Li, L, Chen, X, Zhang, L, Takahashi, Y, Yang, JW, Han, B, Liao, JJ, Li, Y, Harvey, H, Ryazanov, A, Robertson, G, Wan, G, Liu, D, Chen, AF, Tao, Y & Yang, J-M 2018, 'Correction to: eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis (Oncogene, (2016), 35, 49, (6293-6308), 10.1038/onc.2016.166)', Oncogene, vol. 37, no. 33, pp. 4633-4634. https://doi.org/10.1038/s41388-018-0322-0

2017

Somlo, G, Frankel, PH, Arun, BK, Ma, CX, Garcia, AA, Cigler, T, Cream, L, Harvey, H, Sparano, JA, Nanda, R, Chew, HK, Moynihan, TJ, Vahdat, LT, Goetz, MP, Beumer, JH, Hurria, A, Mortimer, J, Piekarz, R, Sand, S, Herzog, J, Van Tongeren, LR, Ferry-Galow, KV, Chen, AP, Ruel, C, Newman, EM, Gandara, DR & Weitzel, JN 2017, 'Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083', Clinical Cancer Research, vol. 23, no. 15, pp. 4066-4076. https://doi.org/10.1158/1078-0432.CCR-16-2714
Jia, H, Truica, C, Wang, B, Wang, Y, Ren, X, Harvey, H, Song, J & Yang, J-M 2017, 'Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects', Drug Resistance Updates, vol. 32, pp. 1-15. https://doi.org/10.1016/j.drup.2017.07.002
Yin, M, Wang, W, Drabick, J & Harvey, H 2017, 'Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: A comparative study', BMC Cancer, vol. 17, no. 1, 295. https://doi.org/10.1186/s12885-017-3292-7

2016

Cheng, Y, Ren, X, Yuan, Y, Shan, Y, Li, L, Chen, X, Zhang, L, Takahashi, Y, Yang, JW, Han, B, Liao, JJ, Li, Y, Harvey, H, Ryazanov, A, Robertson, G, Wan, G, Liu, D, Chen, AF, Tao, Y & Yang, J-M 2016, 'EEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis', Oncogene, vol. 35, no. 49, pp. 6293-6308. https://doi.org/10.1038/onc.2016.166
Yin, M, Joshi, M, Meijer, RP, Glantz, M, Holder, S, Harvey, H, Kaag, MG, Van De Putte, EEF, Horenblas, S & Drabick, J 2016, 'Neoadjuvant chemotherapy for muscle-invasive bladder cancer: A systematic review and two-step meta-analysis', Oncologist, vol. 21, no. 6, pp. 708-715. https://doi.org/10.1634/theoncologist.2015-0440
Yin, M, Mackley, H, Drabick, J & Harvey, H 2016, 'Primary female breast sarcoma: Clinicopathological features, treatment and prognosis', Scientific reports, vol. 6, 31497. https://doi.org/10.1038/srep31497

2015

Al-Marrawi, MY, Cream, L, Mallon, CA, Holder, S, Joshi, M, Harvey, H, Talamo, G & Drabick, J 2015, 'Effect of topical vaginal androgens in a woman on the testosterone levels of her sexual partner with prostate cancer' Journal of Clinical Oncology, vol. 33, no. 5, pp. 521-522. https://doi.org/10.1200/JCO.2014.59.7773
El-Deiry, WS, Vijayvergia, N, Xiu, J, Scicchitano, A, Lim, B, Yee, NS-S, Harvey, H, Gatalica, Z & Reddy, S 2015, 'Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites', Cancer Biology and Therapy, vol. 16, no. 12, pp. 1726-1737. https://doi.org/10.1080/15384047.2015.1113356

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)